ZA978427B - Method of treating urinary incontinence - Google Patents

Method of treating urinary incontinence

Info

Publication number
ZA978427B
ZA978427B ZA978427A ZA978427A ZA978427B ZA 978427 B ZA978427 B ZA 978427B ZA 978427 A ZA978427 A ZA 978427A ZA 978427 A ZA978427 A ZA 978427A ZA 978427 B ZA978427 B ZA 978427B
Authority
ZA
South Africa
Prior art keywords
urinary incontinence
treating urinary
treating
incontinence
urinary
Prior art date
Application number
ZA978427A
Inventor
Michael J Gast
Theodore R Koziol
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24909720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA978427(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Home Prod filed Critical American Home Prod
Publication of ZA978427B publication Critical patent/ZA978427B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA978427A 1996-09-19 1997-09-18 Method of treating urinary incontinence ZA978427B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72426396A 1996-09-19 1996-09-19

Publications (1)

Publication Number Publication Date
ZA978427B true ZA978427B (en) 1999-06-18

Family

ID=24909720

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA978427A ZA978427B (en) 1996-09-19 1997-09-18 Method of treating urinary incontinence

Country Status (7)

Country Link
EP (1) EP0927034A1 (en)
JP (1) JP2001502302A (en)
KR (1) KR20010029519A (en)
AU (1) AU4421697A (en)
CA (1) CA2266070A1 (en)
WO (1) WO1998011888A1 (en)
ZA (1) ZA978427B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1039882E (en) * 1998-08-27 2011-01-03 Pfizer Health Ab Therapeutic formulation for administering tolterodine with controlled release
SK6412002A3 (en) 1999-11-11 2002-09-10 Pharmacia Ab Pharmaceutical formulation containing tolterodine and its use
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
GB0029903D0 (en) * 2000-12-07 2001-01-24 Arakis Ltd Use of anti-muscarinic agents
GB0030580D0 (en) * 2000-12-15 2001-01-31 Medicare Man Consultancy Ltd Composition and method
DE10103262A1 (en) * 2001-01-25 2002-08-01 Axel Schmidt-Dossi Suppository containing oxybutynin, useful for treatment of incontinence, avoids side effects and allows an increase in dose
AU2002336472B2 (en) * 2001-10-02 2007-08-23 Kimberly-Clark Worldwide, Inc. Inhibition of exoprotein production using aromatic compositions
US6773421B2 (en) 2001-12-14 2004-08-10 Kimberly-Clark Worlwide, Inc. Combination for managing the involuntary loss of bladder control
JP2005513080A (en) * 2001-12-20 2005-05-12 フェムファーマ， インコーポレイテッド Vaginal delivery of drugs
US7005138B2 (en) * 2001-12-21 2006-02-28 Duramed Pharmaceuticals, Inc. Method of systematically delivering SSRIs
GB0207104D0 (en) * 2002-03-26 2002-05-08 Pfizer Ltd Stable hydrate of a muscarinic receptor antagonist
FR2843303B1 (en) * 2002-08-07 2006-01-21 R & D Pharma NOVEL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE
AU2003287248A1 (en) * 2002-11-12 2004-06-03 Pharmacia And Upjohn Company Combination therapy for postmenopausal female sexual dysfunction comprising an androgen, an estrogen and an antimuscarinic
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
MXPA05007266A (en) 2003-01-02 2006-01-17 Femmepharma Holding Co Inc Pharmaceutical preparations for treatments of diseases and disorders of the breast.
US20040248989A1 (en) * 2003-06-05 2004-12-09 Risto Santti Method for the treatment or prevention of lower urinary tract symptoms
DE10356112A1 (en) * 2003-11-27 2005-06-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg A pharmaceutical composition of a beta-3 adrenoceptor agonist and a progglandin metabolite
RU2480207C2 (en) 2006-05-22 2013-04-27 Хормос Медикал Лтд. Method of treating chronic abacterial prostatitis with selective modulators of estrogen receptors or aromatase inhibitors
US20110003000A1 (en) 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
US10010514B2 (en) 2010-07-08 2018-07-03 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for reducing frequency of urination and method of use thereof
US9532959B2 (en) 2010-07-08 2017-01-03 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for reducing frequency of urination and method of use thereof
WO2015187183A1 (en) * 2014-06-06 2015-12-10 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for reducing frequency of urination and method of use thereof
US10105328B2 (en) 2014-06-06 2018-10-23 Wellesley Pharmaceuticals, Llc Composition for reducing frequency of urination, method of making and use thereof
GB201601855D0 (en) * 2016-02-02 2016-03-16 Inura Medical Ag Urethral devices for treatment of pathological urological conditions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE910752A1 (en) * 1990-03-08 1991-09-11 Fujisawa Pharmaceutical Co A novel substituted-amine compound and a process for the¹preparation thereof
US5281624A (en) * 1991-09-27 1994-01-25 Eli Lilly And Company N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof
US5234947A (en) * 1991-11-07 1993-08-10 New York University Potassium channel activating compounds and methods of use thereof
JP2549480B2 (en) * 1991-12-10 1996-10-30 ヘキストジャパン株式会社 Urinary disorder improving agent
GB9305295D0 (en) * 1993-03-15 1993-05-05 Zeneca Ltd Therapeutic compounds
GB2278054A (en) * 1993-05-18 1994-11-23 Zeneca Ltd Compounds for the treatment of urinary incontinence
US5441950A (en) * 1994-06-09 1995-08-15 G. D. Searle & Co. Substituted dibenzoxazepine and dibenzthiazepine carbamate compounds, pharmaceutical compositions and methods of use
GB9417135D0 (en) * 1994-08-23 1994-10-12 Medinnova S F Method
US5677346A (en) * 1995-01-31 1997-10-14 Sepracor, Inc. Treating urinary incontinence using (S)-desethyloxybutynin
GB9518953D0 (en) * 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations

Also Published As

Publication number Publication date
CA2266070A1 (en) 1998-03-26
KR20010029519A (en) 2001-04-06
EP0927034A1 (en) 1999-07-07
WO1998011888A1 (en) 1998-03-26
JP2001502302A (en) 2001-02-20
AU4421697A (en) 1998-04-14

Similar Documents

Publication Publication Date Title
ZA978427B (en) Method of treating urinary incontinence
IL117956A0 (en) Use of alpha1l-agonists for treating urinary incontinence
AU8480098A (en) Apparatus and method for treating female urinary incontinence
GB9425578D0 (en) redial treatment of urinary incontinence
HK1039739B (en) Surgical tape for treating female urinary incontinence
PL330752A1 (en) Pharmaceutical agent for treating urinary incontinence
EP0771203A4 (en) Method of treating sweat-related conditions
EP1100402A4 (en) Implantable stimulator system and method for treatment of urinary incontinence
AU4034097A (en) Method of treating ammonia-comprising waste water
IL133078A0 (en) Method of treating nitrate-induced tolerance
ZA977564B (en) Method of treatment
AU2807297A (en) Methods of treating wastewater
PL327600A1 (en) Method of treating depressions
AU3166397A (en) A method and a probe for treatment of incontinence
EP0909172A4 (en) Methods and compositions for treating urinary incontinence using enantiomerically enriched (r,s)-glycopyrrolate
GB9601915D0 (en) Method of treating waste effluent
AU4672597A (en) Method for treating urinary reflux
EP0909163A4 (en) Methods and compositions for treating urinary incontinence using enantiomerically enriched (s,r)-glycopyrrolate
PL341667A1 (en) Method of treating cooped
HUP0104514A2 (en) The use of aril-substituted cyclobutylalkylamines for treating urinary incontinence
EP0938296A4 (en) Method of treating alopecia
GB9618341D0 (en) Method of treatment
ZA973988B (en) Method of treatment
AU1196601A (en) Methods of diagnosing and treating urinary incontinence
AUPP508798A0 (en) Method of treating psoriasis